Detection method and production process for ceftizoxime sodium preparation

A technology of ceftizoxime sodium and ceftizoxime acid, which is applied in the field of medicine and can solve problems such as uncollected

Inactive Publication Date: 2012-02-15
SUZHOU ERYE PHARMA CO LTD
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The 2005 edition of the Chinese Pharmacopoeia has clearly formulated polymer control indicators for the 13 standards of the 7 antibiotic varieties included in it, but this species is not included in the 2005 edition of the Chinese Pharmacopoeia

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Detection method and production process for ceftizoxime sodium preparation
  • Detection method and production process for ceftizoxime sodium preparation
  • Detection method and production process for ceftizoxime sodium preparation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0055] 1. The process conditions for preparing ceftizoxime sodium

[0056] Reaction temperature 28°C, anhydrous sodium carbonate: ceftizoxamic acid (mass ratio) = 0.15: 1.0, reaction time 1.5h, control the pH value before crystallization to 6.7, ethanol: ceftizoxamic acid = 30ml: 1.0g, ethanol drops The acceleration is 450ml / h, and the crystal growth time is 2h. The product yield reaches 95.5%, and the product quality meets the Pharmacopoeia standard.

[0057] 2. The process conditions for preparing ceftizoxime sodium

[0058] Reaction temperature 30 ℃, anhydrous sodium carbonate: ceftizoxamic acid (mass ratio) = 0.15: 1.0, reaction time 2h, control pH value before crystallization is 7.0, ethanol: ceftizoxamic acid = 30ml: 1.0g, ethanol drop rate 450ml / h, crystal growth time 2h. The product yield reaches 96%, and the product quality meets the Pharmacopoeia standard.

[0059] 3. Inspection of polymers in ceftizoxime sodium injection preparations

[0060] The chromatographi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
ionic strengthaaaaaaaaaa
Login to view more

Abstract

The invention discloses a preparation method and a detection method for ceftizoxime sodium. Various factors which influence the quality and yield of the product in the process of producing the ceftizoxime sodium are subjected to experimental analysis and research, and optimal process conditions for producing the ceftizoxime sodium are obtained; and a method which meets the requirement of a national medicine inspection sample and is used for measuring ceftizoxime sodium high polymer is established.

Description

[0001] technical field [0002] The invention belongs to the technical field of medicine, and in particular relates to a method for preparing and detecting ceftizoxime sodium. Background technique [0003] Ceftizoxime sodium (ceftizoxime sodium) is also known as Yibao Shiling, and its main component and chemical name are {[ 6R-[ 6 ( , 7 ( ( Z ) ) ) ] -7{[ [ 2, 3-dihydro -2-imino-4-thiazolyl](methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]octane-2 -ene-2-carboxylic acid sodium salt. Its structural formula is as follows: [0004] Molecular formula: C 13 h 12 N 5 NaO 5 S 2 [0005] Molecular weight: 405.39 [0006] The third-generation cephalosporin antibiotic developed for Fujisawa Pharmaceutical Co., Ltd. (Fujisawa), Japan, has the characteristics of being stable to β-lactamase, and has a wide antibacterial spectrum, low toxicity, enzyme resistance, low toxicity and permeability It crosses the blood-brain barrier and is widely used clinically. [0007] ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D501/20C07D501/04G01N30/02
Inventor 蒋芸朱炜郭顺王宁
Owner SUZHOU ERYE PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products